Scholarlink

Background <p>Food-derived glucosylceramides (GlcCer) have been used for functional foods; however, limited information is currently available on their safety. Therefore, we examined the toxicity of repeated oral dose and mutagenicity of rice-derived GlcCer (RGlcCer).</p> Methods <p>RGlcCer containing 3% GlcCer was administered to mice in a 28-d repeated-dose oral toxicity study. Ames test and in vitro micronucleus test was performed followed OECD guideline.</p> Results <p>Spontaneous motor suppression, sedation, and convulsions were observed prior to mortality in all animals treated with 6,000&#xa0;mg/kg/d body weight RGlcCer (equivalent to 180&#xa0;mg/kg/d body weight of GlcCer). Mice administered 600&#xa0;mg/kg/d RGlcCer exhibited the same clinical symptoms as the high dose group, although to a milder extent and only during the first half of the treatment period. While a decrease in body weight was noted in the 600&#xa0;mg/kg/d group, it recovered with continued administration, and no abnormalities were observed in blood, pathological, and anatomical examinations following the treatment period. At a dose of 60&#xa0;mg/kg/d, no abnormalities were detected in any parameters. No mutagenicity was observed in either in vitro test.</p> Conclusion <p>The repeated oral administration of 600&#xa0;mg/kg/d RGlcCer to mice for 28 d was considered safe and the lowest observed adverse effect level was 600&#xa0;mg/kg/d RGlcCer under our study conditions. The effects of concentrated RGlcCer (CRGlcCer) consisting of 10% rice GlcCer were examined in a mutagenicity study. The results of the Ames test and in vitro micronucleus test showed that CRGlcCer did not induce mutagenic changes. In conclusion, RGlcCer is safe, is not mutagenic, and did not cause chromosomal damage.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Short-term repeated-dose oral toxicity and mutagenicity studies on rice-derived glucosylceramides

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年7月7日

查看全文
  • Hiroshi Shimoda,
  • Norityuki Yamazaki,
  • Terry Maniatis,
  • Aldona Kenthol,
  • Kristin Lopez,
  • John C. Fanaras,
  • Eirini Karamariti

摘要

Background

Food-derived glucosylceramides (GlcCer) have been used for functional foods; however, limited information is currently available on their safety. Therefore, we examined the toxicity of repeated oral dose and mutagenicity of rice-derived GlcCer (RGlcCer).

Methods

RGlcCer containing 3% GlcCer was administered to mice in a 28-d repeated-dose oral toxicity study. Ames test and in vitro micronucleus test was performed followed OECD guideline.

Results

Spontaneous motor suppression, sedation, and convulsions were observed prior to mortality in all animals treated with 6,000 mg/kg/d body weight RGlcCer (equivalent to 180 mg/kg/d body weight of GlcCer). Mice administered 600 mg/kg/d RGlcCer exhibited the same clinical symptoms as the high dose group, although to a milder extent and only during the first half of the treatment period. While a decrease in body weight was noted in the 600 mg/kg/d group, it recovered with continued administration, and no abnormalities were observed in blood, pathological, and anatomical examinations following the treatment period. At a dose of 60 mg/kg/d, no abnormalities were detected in any parameters. No mutagenicity was observed in either in vitro test.

Conclusion

The repeated oral administration of 600 mg/kg/d RGlcCer to mice for 28 d was considered safe and the lowest observed adverse effect level was 600 mg/kg/d RGlcCer under our study conditions. The effects of concentrated RGlcCer (CRGlcCer) consisting of 10% rice GlcCer were examined in a mutagenicity study. The results of the Ames test and in vitro micronucleus test showed that CRGlcCer did not induce mutagenic changes. In conclusion, RGlcCer is safe, is not mutagenic, and did not cause chromosomal damage.